Attached files
| file | filename |
|---|---|
| 10-K - 10-K - PIERIS PHARMACEUTICALS, INC. | pirs-20201231.htm |
| EX-32.2 - EX-32.2 - PIERIS PHARMACEUTICALS, INC. | pirs12312020ex322.htm |
| EX-31.2 - EX-31.2 - PIERIS PHARMACEUTICALS, INC. | pirs12312020ex312.htm |
| EX-31.1 - EX-31.1 - PIERIS PHARMACEUTICALS, INC. | pirs12312020ex311.htm |
| EX-23.1 - EX-23.1 - PIERIS PHARMACEUTICALS, INC. | pirs12312020ex231.htm |
| EX-21.1 - EX-21.1 - PIERIS PHARMACEUTICALS, INC. | pirs12312020ex211.htm |
| EX-14.1 - EX-14.1 - PIERIS PHARMACEUTICALS, INC. | a210317pirsethicsandwhis.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Pieris Pharmaceuticals, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2020 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 31, 2021 | /s/ Stephen S. Yoder | |||||||
| Stephen S. Yoder | ||||||||
| Title: | Chief Executive Officer and President | |||||||
| (principal executive officer) | ||||||||